$98.35
1.441.49%
At Close: -
$98.33
-0.02-0.02%
After Hours: 5:54 PM EDT
15 minutes delayed
Comments
Loading...
Cardinal Health
CAHNYSE
Cardinal Health (NYSE:CAH) Stock, Analyst Ratings, Price Targets, Forecasts
Cardinal Health Inc has a consensus price target of $94.36 based on the ratings of 22 analysts. The high is $130 issued by Baird on July 9, 2024. The low is $54 issued by Morgan Stanley on December 17, 2021. The 3 most-recent analyst ratings were released by Citigroup, Evercore ISI Group, and Baird on July 19, 2024, July 9, 2024, and July 9, 2024, respectively. With an average price target of $114 between Citigroup, Evercore ISI Group, and Baird, there's an implied 15.91% upside for Cardinal Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Evercore ISI Group
Baird
Argus Research
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Cardinal Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/19/2024 | Buy Now | 8.8% | Citigroup | Daniel Grosslight | $115 → $107 | Maintains | Neutral | Get Alert |
| 07/09/2024 | Buy Now | 6.76% | Evercore ISI Group | Elizabeth Anderson | $115 → $105 | Maintains | In-Line | Get Alert |
| 07/09/2024 | Buy Now | 32.18% | Baird | Eric Coldwell | $129 → $130 | Maintains | Outperform | Get Alert |
| 05/15/2024 | Buy Now | 16.93% | Argus Research | David Toung | $120 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 16.93% | Evercore ISI Group | Elizabeth Anderson | $110 → $115 | Maintains | In-Line | Get Alert |
| 05/03/2024 | Buy Now | 30.15% | Baird | Eric Coldwell | $134 → $128 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | -4.42% | Wells Fargo | Stephen Baxter | $96 → $94 | Maintains | Underweight | Get Alert |
| 02/26/2024 | Buy Now | 27.1% | Leerink Partners | Michael Cherny | → $125 | Initiates | → Outperform | Get Alert |
| 02/09/2024 | Buy Now | — | Argus Research | David Toung | — | Upgrade | Hold → Buy | Get Alert |
| 02/05/2024 | Buy Now | 27.1% | UBS | Kevin Caliendo | $122 → $125 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | 24.05% | UBS | Kevin Caliendo | $114 → $122 | Maintains | Buy | Get Alert |
| 01/03/2024 | Buy Now | 18.96% | Barclays | Stephanie Davis | → $117 | Initiates | → Overweight | Get Alert |
| 12/14/2023 | Buy Now | -2.39% | Wells Fargo | Stephen Baxter | → $96 | Initiates | → Underweight | Get Alert |
| 11/17/2023 | Buy Now | 13.88% | JP Morgan | Lisa Gill | $101 → $112 | Maintains | Neutral | Get Alert |
| 11/06/2023 | Buy Now | 5.74% | Mizuho | Ann Hynes | $95 → $104 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | -8.49% | TD Cowen | Charles Rhyee | $88 → $90 | Maintains | Market Perform | Get Alert |
| 08/16/2023 | Buy Now | 2.69% | JP Morgan | Lisa Gill | $93 → $101 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | 1.68% | Morgan Stanley | Erin Wright | $92 → $100 | Maintains | Overweight | Get Alert |
| 08/16/2023 | Buy Now | 9.81% | Baird | Eric Coldwell | $107 → $108 | Maintains | Outperform | Get Alert |
| 08/16/2023 | Buy Now | -2.39% | Mizuho | Ann Hynes | $94 → $96 | Maintains | Neutral | Get Alert |
| 07/11/2023 | Buy Now | -4.42% | Mizuho | Ann Hynes | $85 → $94 | Maintains | Neutral | Get Alert |
| 07/10/2023 | Buy Now | 1.68% | Evercore ISI Group | Elizabeth Anderson | → $100 | Downgrade | Outperform → In-Line | Get Alert |
| 06/12/2023 | Buy Now | -8.49% | Citigroup | Daniel Grosslight | $88 → $90 | Maintains | Neutral | Get Alert |
| 06/12/2023 | Buy Now | -13.57% | Barclays | Steven Valiquette | $80 → $85 | Maintains | Equal-Weight | Get Alert |
| 06/12/2023 | Buy Now | 1.68% | Credit Suisse | Jonathan Yong | $90 → $100 | Maintains | Neutral | Get Alert |
| 06/12/2023 | Buy Now | -1.37% | UBS | Kevin Caliendo | $93 → $97 | Maintains | Buy | Get Alert |
| 06/09/2023 | Buy Now | -5.44% | JP Morgan | Lisa Gill | $90 → $93 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | -10.52% | Citigroup | Daniel Grosslight | $77 → $88 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | -8.49% | Deutsche Bank | George Hill | $88 → $90 | Maintains | Hold | Get Alert |
| 05/05/2023 | Buy Now | -10.52% | Barclays | Steven Valiquette | $77 → $88 | Maintains | Equal-Weight | Get Alert |
| 04/26/2023 | Buy Now | -10.52% | Deutsche Bank | George Hill | $77 → $88 | Maintains | Hold | Get Alert |
| 03/31/2023 | Buy Now | -21.71% | Citigroup | Daniel Grosslight | → $77 | Initiates | → Neutral | Get Alert |
| 03/22/2023 | Buy Now | -21.71% | Deutsche Bank | George Hill | $82 → $77 | Maintains | Hold | Get Alert |
| 02/03/2023 | Buy Now | -6.46% | Credit Suisse | Jonathan Yong | $89 → $92 | Maintains | Neutral | Get Alert |
| 02/03/2023 | Buy Now | -8.49% | Morgan Stanley | Erin Wright | $86 → $90 | Maintains | Overweight | Get Alert |
| 02/03/2023 | Buy Now | -4.42% | Baird | Eric Coldwell | $87 → $94 | Upgrade | Neutral → Outperform | Get Alert |
| 01/31/2023 | Buy Now | -7.47% | UBS | Kevin Caliendo | $78 → $91 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | -12.56% | Morgan Stanley | Erin Wright | $82 → $86 | Maintains | Overweight | Get Alert |
| 11/22/2022 | Buy Now | -19.67% | Credit Suisse | A.J. Rice | $64 → $79 | Maintains | Neutral | Get Alert |
| 11/14/2022 | Buy Now | -24.76% | Mizuho | Ann Hynes | $66 → $74 | Maintains | Neutral | Get Alert |
| 11/07/2022 | Buy Now | -16.62% | Morgan Stanley | Erin Wright | $76 → $82 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | -16.62% | Baird | Eric Coldwell | $74 → $82 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | -18.66% | B of A Securities | Michael Cherny | $64 → $80 | Upgrade | Underperform → Neutral | Get Alert |
| 08/29/2022 | Buy Now | -20.69% | UBS | Kevin Caliendo | $61 → $78 | Maintains | Buy | Get Alert |
| 08/22/2022 | Buy Now | -22.72% | Morgan Stanley | Erin Wright | $70 → $76 | Maintains | Overweight | Get Alert |
| 08/16/2022 | Buy Now | -26.79% | Cowen & Co. | Charles Ryhee | $59 → $72 | Maintains | Market Perform | Get Alert |
| 08/12/2022 | Buy Now | -34.93% | Credit Suisse | A.J. Rice | $56 → $64 | Maintains | Neutral | Get Alert |
| 08/12/2022 | Buy Now | -25.78% | Baird | Eric Coldwell | $57 → $73 | Maintains | Neutral | Get Alert |
| 07/14/2022 | Buy Now | -28.83% | Morgan Stanley | Ricky Goldwasser | $74 → $70 | Maintains | Overweight | Get Alert |
| 05/26/2022 | Buy Now | -34.93% | Barclays | Steve Valiquette | $70 → $64 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/18/2022 | Buy Now | -30.86% | Evercore ISI Group | Elizabeth Anderson | → $68 | Upgrade | In-Line → Outperform | Get Alert |
| 05/06/2022 | Buy Now | -43.06% | Credit Suisse | A.J. Rice | $58 → $56 | Maintains | Neutral | Get Alert |
| 04/12/2022 | Buy Now | -24.76% | Morgan Stanley | Ricky Goldwasser | → $74 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/04/2022 | Buy Now | -41.03% | Credit Suisse | Jailendra Singh | $60 → $58 | Maintains | Neutral | Get Alert |
| 01/11/2022 | Buy Now | -35.94% | Barclays | Steve Valiquette | $65 → $63 | Maintains | Overweight | Get Alert |
| 12/17/2021 | Buy Now | -45.09% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 11/15/2021 | Buy Now | -49.16% | Credit Suisse | Jailendra Singh | — | Maintains | Neutral | Get Alert |
| 11/10/2021 | Buy Now | -33.91% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
| 08/06/2021 | Buy Now | -30.86% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
| 08/06/2021 | Buy Now | -48.14% | Deutsche Bank | George Hill | — | Downgrade | Buy → Hold | Get Alert |
| 08/05/2021 | Buy Now | -43.06% | B of A Securities | Michael Cherny | — | Downgrade | Buy → Underperform | Get Alert |
FAQ
What is the target price for Cardinal Health (CAH) stock?
The latest price target for Cardinal Health (NYSE:CAH) was reported by Citigroup on July 19, 2024. The analyst firm set a price target for $107.00 expecting CAH to rise to within 12 months (a possible 8.82% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cardinal Health (CAH)?
The latest analyst rating for Cardinal Health (NYSE:CAH) was provided by Citigroup, and Cardinal Health maintained their neutral rating.
When was the last upgrade for Cardinal Health (CAH)?
The last upgrade for Cardinal Health Inc happened on February 9, 2024 when Argus Research raised their price target to N/A. Argus Research previously had a hold for Cardinal Health Inc.
When was the last downgrade for Cardinal Health (CAH)?
The last downgrade for Cardinal Health Inc happened on July 10, 2023 when Evercore ISI Group changed their price target from N/A to $100 for Cardinal Health Inc.
When is the next analyst rating going to be posted or updated for Cardinal Health (CAH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardinal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardinal Health was filed on July 19, 2024 so you should expect the next rating to be made available sometime around July 19, 2025.
Is the Analyst Rating Cardinal Health (CAH) correct?
While ratings are subjective and will change, the latest Cardinal Health (CAH) rating was a maintained with a price target of $115.00 to $107.00. The current price Cardinal Health (CAH) is trading at is $98.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.